KUMAR AMIT

Amit Kumar's 324-transaction insider record breaks into five issuer buckets, but two of them are almost certainly the same company under different names at different points in time. The largest bucket, 150 transactions listed under "ITUS Corp" (ticker ITUSD) running from 2013-01-25 through 2026-07-10, ends on the exact date the most recent transaction in this record — filed under the current name "Anixa Biosciences" (ANIX) — was reported. No separate Anixa Biosciences entry exists in the breakdown, and the five listed issuers' transaction counts sum to exactly 324, the total on file — meaning ITUS Corp and Anixa Biosciences share a CIK, with the company having been renamed at some point inside that 2013-2026 window. The earlier history follows the same thread: Acacia Research Corp, listed under the combined ticker "ACTG/CBMX," ran from 2004-03-04 to 2007-05-04, ending three months before a CombiMatrix Corp relationship began on 2007-08-15 — CombiMatrix's own ticker sits embedded inside Acacia's combined one.

Within the ITUS/Anixa relationship, the buy side is unusually active for this dataset: eleven separate open-market code-P purchases between 2021-07-23 and 2026-07-10, ranging from 2,000 to 43,000 shares at prices between $2.23 and $4.77, together totaling roughly 171,000 shares — real capital commitments layered on top of annual 500,000-to-700,000-share code-A grants (2022, 2023, 2024, 2025) and periodic large option exercises (200,000 shares on 2025-10-30; 640,000 shares on 2022-09-15, the latter followed by a 491,900-share tax-withholding sale at $4.48). Lifetime, the relationship still nets to selling — 2,290,992 shares bought against 20,961,514 sold — but the buy figure is far larger than the near-zero totals typical of the other relationships in this batch.